Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: -
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Services
  • Sub-Industry: Medical-Outptnt/Home Med

LVL Medical Groupe SA

LV3:GR

Ticker Delisted

Snapshot for LVL Medical Groupe SA (LV3)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for LV3

No chart data available.
  • LV3:GR 30.280
  • 1M
  • 1Y
0.000
Interactive LV3 Chart

Previous Close

Key Statistics for LV3

Current P/E Ratio (ttm) -
Estimated P/E(09/2012) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS (09/2012) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Last Dividend 03/10/2011
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LV3

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for LV3

LVL Medical Groupe SA supplies, installs and maintains medical equipment for home treatment of respiratory diseases, AIDS, depression and other illnesses. The Company also provides at-home antibiotic therapy and chemotherapy.

Jean-Claude LavorelChairman/CEO/FounderThierry MontagneChief Financial Officer
Stanislas LavorelCo-COOGilbert HabyCo-COO
More Company Profile & Key Executives for LV3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil